The American College of Cardiology recently released recommendations indicating that inflammation should be considered when trying to predict heart disease.
In a report issued in the Journal of the American College of Cardiology on Sept. 29, the college said that the high-sensitivity C-reactive protein (hsCRP) blood test that measures CRP, a known inflammatory marker that increases in response to inflammation in the body, can determine whether a person is at risk of developing cardiovascular disease (CVD).
“Because clinicians will not treat what they do not measure, universal screening of hsCRP in both primary and secondary prevention patients, in combination with cholesterol, represents a major clinical opportunity and is therefore recommended,” said the American College of Cardiology….